TENAX THERAPEUTICS, INC.

TENX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0000034956

Price chart

Open-market purchases and sales by TENX insiders, newest first.

Insider trades
Filed (ET)Trade dateInsiderTransactionSharesAvg priceValueShares afterHolding changeFiling
Sep 17, 20269:30 PM ETSep 16, 2026Doogan DeclanDirectorPPurchaseCommon Stock+53K$1.92+$101.76K55.27K+2,330.7%SEC
Sep 15, 20269:38 PM ETSep 11 – Sep 15, 2026Giordano Christopher ThomasCEOPPurchaseCommon Stock+10.85K$1.8514+$20.09K22.17K+95.8%SEC
Sep 15, 20269:30 PM ETSep 11, 2026STAAB THOMAS R IIChief Financial OfficerPPurchaseCommon Stock+5.68K$1.935+$10.98K15.68K+56.8%SEC
Sep 8, 20265:16 PM ETSep 3, 2026Schneeberger Daniel and 1 other10% OwnerPPurchaseCommon Stock+900K$1.7824+$1.6M6.52M+16.0%SEC
Sep 2, 20265:52 PM ETAug 31 – Sep 2, 2026Schneeberger Daniel and 1 other10% OwnerPPurchaseCommon Stock+770.33K$1.7937+$1.38M5.62M+15.9%SEC

The largest institutional positions in TENX at the end of Q2 2026.

Institutions holding TENX in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
FMR LLC3,942,373$57.36M0.00%+3,619,773+1,122.1%Added
Vivo Capital, LLC2,500,000$36.38M3.32%+2,291,667+1,100.0%Added
BlackRock, Inc.1,727,988$25.14M0.00%+1,711,011+10,078.4%Added
PERCEPTIVE ADVISORS LLC1,700,000$24.74M0.38%+252,218+17.4%Added
VANGUARD CAPITAL MANAGEMENT LLC1,147,121$16.69M0.00%+883,700+335.5%Added